• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Darren Wheeler, MD

Latest:

Reducing Delays in Breast Cancer Care Using an Innovative Digital Health Platform

The use of a novel digital health platform achieved a 55% reduction in time to treatment among women with a new diagnosis of breast cancer.


LaVarne A. Burton

Latest:

Contributor: Medicare Policy Proposal Jeopardizes Care for Those on Dialysis

CEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.


Paul M. Coplan, PhD, MBA

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Eric Kwok, BS

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Esther Adeniran, DrPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.



Alexander Beschloss, MD, MBA

Latest:

Contributor: Roadmap to the Quadruple Aim—A Framework for Minimizing Physician Burnout During the Transition to Value-Based Care

As provider and payer organizations pursue the Quadruple Aim, it is important that they take into account not just the contracting but also the transformation in staffing, clinical workflows, and culture as these organizations evolve.


Elena Andreyeva, PhD

Latest:

Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population

Residence in a more disadvantaged neighborhood was associated with higher likelihood of being a high-cost utilizer among older adults and lower likelihood among younger adults.


Jason Porter, MD

Latest:

ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions

Jason Porter, MD, provides concluding insights on the LAURA phase 3 trial, CHRYSALIS-2 study, TROPION-Lung05 trial, and CheckMate 9LA study, along with other notable findings from the ASCO 2024 conference.


Adam J. Milam, MD, PhD

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Wendy K. Chung, MD, PhD

Latest:

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.


Tam Dang-Tan, PhD

Latest:

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.



Kanaka D. Shetty, MD, MS

Latest:

Actions to Improve Quality: Results From a National Hospital Survey

Hospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.


Minakshi Raj, PhD, MPH

Latest:

Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey

Patients’ motivations for telehealth use require further investigation to develop appropriate policies.


Saria Awadalla, PhD

Latest:

Adherence Patterns 1 Year After Initiation of SGLT2 Inhibitors: Results of a National Cohort Study

This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the adherence trajectory groups.



Anders H. Nyberg, MD, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Aaron Brice, MD

Latest:

Telehealth User Experiences During COVID-19: A Case Study of Outpatient Cardiovascular Clinics Affiliated With a Large Academic Practice

In cardiovascular clinics during COVID-19, notable barriers to successful telehealth use included obtaining diagnostic information needed to deliver high-quality care and technology-related challenges for patients.


Edward Li, PharmD, MPH

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.


Todd Norwood, DPT

Latest:

The Value of Virtual Physical Therapy for Musculoskeletal Care

This counterfactual simulation study on a nationally representative sample of the working population with musculoskeletal conditions estimated the value of patient-initiated virtual physical therapy.


Edward W. Aberger, PhD

Latest:

Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs

The Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.


Nicholas Dorich, PharmD

Latest:

Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates

Patients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.


Emma Ciafaloni, MD

Latest:

Unmet Needs and the Future of Treatment in SMA

Experts in SMA provide closing thoughts on unmet needs in SMA including the importance of research into treatment combinations and sequencing as well as multidisciplinary care and healthcare equity.


Sarah MacCarthy, ScD

Latest:

Sex Differences in Medicare Beneficiaries’ Experiences by Low-Income Status

Only low-income male Medicare beneficiaries had worse patient experience than their female counterparts. The authors discuss opportunities to improve experiences for all patients.


Quinn Quackenbush, MSN, RN

Latest:

Implementing Clinical Informatics Tools for Primary Care–Based Diabetic Retinopathy Screening

The authors describe a primary care–based diabetic retinopathy screening program incorporating telemedicine, strong health information technology engagement, and development of clinical informatics tools.


Hechuan Hou, MS

Latest:

Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.



Mark G. Kris, MD

Latest:

Comprehensive Genomic Profiling in Community Oncology

Recommendations to address limitations in more widespread use of reflex testing in community oncology.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.